The BETY-Biopsychosocial Questionnaire (BETY-BQ) in Individuals With Temporomandibular Dysfunction-Related Headache
Launched by HASAN KALYONCU UNIVERSITY · Jun 4, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The BETY-Biopsychosocial Questionnaire (BETY-BQ) study is looking at how effective and reliable a new questionnaire can be for understanding headaches related to jaw problems, known as temporomandibular dysfunction (TMD). Researchers want to see if this tool can help identify and assess the various factors—like physical, emotional, and social influences—that contribute to these headaches.
To participate, you need to be between 18 and 60 years old and have been diagnosed with a TMD-related headache for at least six months. You should also be experiencing significant pain, but not be currently receiving certain treatments like physical therapy or medication for your headaches. If you join the study, you can expect to fill out questionnaires and take part in assessments that focus on your pain and its impact on your life. This trial is open to all genders, and it aims to help improve how healthcare providers understand and treat headaches related to jaw issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages between 18 and 60 years old
- • Getting a diagnosis of TMD-related headache
- • Not having received FTR and manual therapy in the last 3 months
- • Having pain ≥ 50 or more according to the headache impact test (HIT 6)
- • Patients who have not received medical treatment in the last 3 months and will not receive medical treatment during the treatment
- • Patients who describe pain in the jaw, face, temporal region, or ear for at least 6 months and who have pain in the chewing muscles with palpation
- Exclusion Criteria:
- • Ages under 18 and over 60 years old
- • Patients with disc displacement and attachment degeneration
- • Patients with dental infection
- • Patients who have undergone facial and ear surgery in the last six months
- • Patients undergoing orthodontic treatment
- • Patients using regular analgesics or anti-inflammatory drugs
- • Patients with a history of trauma (whiplash injury, condylar trauma, fracture),
- • Patients who have undergone any surgery related to the cervical and TMJ
- • Patients with facial paralysis
- • Patients with missing teeth in the upper jaw
- • Patients with cognitive deficits
- • Participation rate lower than 80% of the program schedule
About Hasan Kalyoncu University
Hasan Kalyoncu University is a distinguished academic institution dedicated to advancing research and education in the health sciences. With a commitment to innovation and excellence, the university actively sponsors clinical trials aimed at enhancing medical knowledge and improving patient outcomes. By fostering collaboration among researchers, healthcare professionals, and industry partners, Hasan Kalyoncu University strives to contribute to the development of effective therapies and interventions, ultimately aiming to address pressing health challenges and promote public well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gaziantep, Hasan Kalyoncu University, Turkey
Patients applied
Trial Officials
Aysenur TUNCER, PhD
Study Director
Hasan Kalyoncu University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported